![](/fileadmin/_processed_/csm_drugs_pills_-web_4e35a70ff4.jpg)
Ten drug recommendations by EMA
The committee recommended end of June granting a marketing authorisation for Balversa (erdafitinib), for the treatment of adult...
![](/fileadmin/_processed_/csm_dollars-499481_1280-_Gerd_Altmann_pixabay_55a91b9ae7.jpg)
Forbion closes first Bioeconomy Fund with US$75m
Life Science investor Forbion opens a new sector for its lead partners who were eager to put money into industries within the ESG standards. At...
![](/fileadmin/_processed_/csm_EuroscreenFast_s_headquarters_23b7550a4f.jpg)
EuroscreenFast and GW Vitek announce distribution partnership in Korea
According to the agreement, GW Vitek will represent EuroscreenFast’s discovery and lead optimisation capabilities in the Republic of Korea....
![](/fileadmin/_processed_/csm_Electrochea_process_c40cabeed1.png)
Electrochaea sells biomethane reactor to Again A/S
Like German bio-CH4 producer Electrochea GmbH, Danish Again A/S is using CO2-fxing archaea, but to manufacture carbon-negative chemicals such...
![](/fileadmin/_processed_/csm_Myricx_Bio3_366906b8af.png)
Novo Holdings and Abingworth co-lead £90m financing in Myricx Bio Ltd
Novo Holdings co-led the financing together with Abingworth; new investors British Patient Capital (BPC) and Eli Lilly & Company, as well as seed...
![](/fileadmin/Content/NewsAndStories/2024/Enk_freitag.png)
Friday: CRISPR screen highlights genes behind T cell plasticity in autoimmunity
Pro-inflammatory CD4-positive T cells are major drivers of autoimmune diseases, yet therapiesmodulating T cell phenotypes to promote an...
![](/fileadmin/_processed_/csm_Evotec_HQ_516a5db450.jpg)
Consortium led by Evotec enters obesity drug space
The newly formed strategic partnership between Evotec SE, Inserm, Lille University Hospital and Inserm Transfert aims to identify novel multimodal...